The document is an intimation of a rescheduled Analyst/Investor Meeting, originally scheduled for Tuesday, 3rd November, 2026, and now moved to Friday, 6th November, 2026.
The meeting will be conducted as a virtual meeting at 3:30 PM IST.
The sole management participant specified is Mr. Ajay Upadhyaya.
The company explicitly states that no unpublished price sensitive information (UPSI) will be discussed during the meeting.
This communication is made pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, read with Part A of Schedule III to the SEBI Listing Regulations.
The original intimation was made via a letter dated 30th October, 2026.
The schedule is noted to be subject to change due to exigencies on the part of the Company or the concerned analysts/investors, with any changes to be intimated to the Stock Exchanges where required.
Additional Notes Section
The document is a formal regulatory filing submitted to both the National Stock Exchange of India Limited (NSE) and BSE Limited (BSE).
No financial data, results, guidance, or strategic updates were disclosed in this announcement.
The letter is signed by Govind Rao, Company Secretary & Compliance Officer (Membership No.: A47094), on behalf of Stallion India Fluorochemicals Limited.
